Implementing wearable sensor technology for the determination of a biomarker profile for cancer-related fatigue

Cancer Related Fatigue (CRF) is a well-recognised symptom of malignant breast disease and may affect up to 70% of those undergoing therapy or deemed to be in remission. The condition is frequently subject to unpredictable recurrence that can result in unavoidable and unforeseen detriment to quality of life. Moreover, management of the condition can place significant financial burden on health and social care facilities. CRF is distinct from normal tiredness which may be resolved by periods of sleep or rest. Customers' extensive use of wearable technologies has contributed to the evolution of clinical trial procedures and, as a result, health data can also be obtained using wearables [1]. New technologies have the potential to improve data accuracy and timeliness, improve efficiency and increasing patient engagement in the clinical trial process Medical quality tracking devices are already supporting patient care in several clinical areas [1]. The main aim of this study is to define an accurate fatigue baseline for individuals diagnosed with breast cancer to determine potential relationships between possible fatigue markers, measurable daily activity and individual perceptions of fatigue.